BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38496640)

  • 1. Cannabinoid CB
    Guenther KG; Lin X; Xu Z; Makriyannis A; Romero J; Hillard CJ; Mackie K; Hohmann AG
    bioRxiv; 2024 Mar; ():. PubMed ID: 38496640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid CB
    Guenther KG; Lin X; Xu Z; Makriyannis A; Romero J; Hillard CJ; Mackie K; Hohmann AG
    Biomed Pharmacother; 2024 Jul; 176():116879. PubMed ID: 38850666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenan-induced inflammatory pain.
    Guenther KG; Xu Z; Romero J; Hillard CJ; Mackie K; Hohmann AG
    Neuropharmacology; 2023 Oct; 237():109601. PubMed ID: 37286073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-retroviral toxic neuropathy.
    Carey LM; Xu Z; Rajic G; Makriyannis A; Romero J; Hillard C; Mackie K; Hohmann AG
    Pharmacol Res; 2023 Jan; 187():106560. PubMed ID: 36417942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cannabinoid CB
    Iyer V; Slivicki RA; Thomaz AC; Crystal JD; Mackie K; Hohmann AG
    Eur J Pharmacol; 2020 Nov; 886():173544. PubMed ID: 32896549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slowly Signaling G Protein-Biased CB
    Lin X; Dhopeshwarkar AS; Huibregtse M; Mackie K; Hohmann AG
    Mol Pharmacol; 2018 Feb; 93(2):49-62. PubMed ID: 29192123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB₂ receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy.
    Deng L; Guindon J; Vemuri VK; Thakur GA; White FA; Makriyannis A; Hohmann AG
    Mol Pain; 2012 Sep; 8():71. PubMed ID: 22998838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
    Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
    Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal.
    Li AL; Lin X; Dhopeshwarkar AS; Thomaz AC; Carey LM; Liu Y; Nikas SP; Makriyannis A; Mackie K; Hohmann AG
    Mol Pharmacol; 2019 Feb; 95(2):155-168. PubMed ID: 30504240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery.
    Rahn EJ; Deng L; Thakur GA; Vemuri K; Zvonok AM; Lai YY; Makriyannis A; Hohmann AG
    Mol Pain; 2014 Apr; 10():27. PubMed ID: 24742127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats.
    Rahn EJ; Zvonok AM; Thakur GA; Khanolkar AD; Makriyannis A; Hohmann AG
    J Pharmacol Exp Ther; 2008 Nov; 327(2):584-91. PubMed ID: 18664590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse.
    Lin X; Xu Z; Carey L; Romero J; Makriyannis A; Hillard CJ; Ruggiero E; Dockum M; Houk G; Mackie K; Albrecht PJ; Rice FL; Hohmann AG
    Pain; 2022 May; 163(5):834-851. PubMed ID: 35001054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid CB
    Zavala CA; Thomaz AC; Iyer V; Mackie K; Hohmann AG
    Cannabis Cannabinoid Res; 2021 Oct; 6(5):389-400. PubMed ID: 33998863
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive Allosteric Modulation of CB
    Slivicki RA; Iyer V; Mali SS; Garai S; Thakur GA; Crystal JD; Hohmann AG
    Front Mol Neurosci; 2020; 13():54. PubMed ID: 32410959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemogenetic Regulation of CX3CR1-Expressing Microglia Using Gi-DREADD Exerts Sex-Dependent Anti-Allodynic Effects in Mouse Models of Neuropathic Pain.
    Saika F; Matsuzaki S; Kobayashi D; Ideguchi Y; Nakamura TY; Kishioka S; Kiguchi N
    Front Pharmacol; 2020; 11():925. PubMed ID: 32636748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain: a selected review of preclinical studies.
    O'Hearn S; Diaz P; Wan BA; DeAngelis C; Lao N; Malek L; Chow E; Blake A
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S209-S214. PubMed ID: 29156899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. δ-Opioid receptors in primary sensory neurons tonically restrain nociceptive input in chronic pain but do not enhance morphine analgesic tolerance.
    Jin D; Chen H; Huang Y; Chen SR; Pan HL
    Neuropharmacology; 2022 Oct; 217():109202. PubMed ID: 35917874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.
    Naguib M; Xu JJ; Diaz P; Brown DL; Cogdell D; Bie B; Hu J; Craig S; Hittelman WN
    Anesth Analg; 2012 May; 114(5):1104-20. PubMed ID: 22392969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
    Slivicki RA; Saberi SA; Iyer V; Vemuri VK; Makriyannis A; Hohmann AG
    J Pharmacol Exp Ther; 2018 Dec; 367(3):551-563. PubMed ID: 30275151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.